![Exploring safety issues in antimicrobial drug development](https://revive.gardp.org/wp-content/uploads/2020/09/GARDP_REVIVE_Poster_2020-Bootcamp_safety-issues-copy_recording_new-colours-scaled-2.jpg)
Exploring safety issues in antimicrobial drug development
more![The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study](https://revive.gardp.org/wp-content/uploads/2020/04/GARDP_REVIVE_Poster_May2020_AAKW1_050620_new-colours-scaled-2.jpg)
The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study
moreCOVID-19 und warum die stille Krise der arzneimittelresistenten Infektionen wichtiger ist denn je – von Manica Balasegaram
more![Assay development for measuring antibiotic accumulation in Gram-negative bacteria](https://revive.gardp.org/wp-content/uploads/2020/04/Pew_poster_final_new-colours-scaled-2.jpg)
Assay development for measuring antibiotic accumulation in Gram-negative bacteria
more![<br>The antibiotics marketplace collapse: It’s just math, and it’s a solvable equation</br><em> – by Ryan Cirz and Kevin Krause</em>](https://revive.gardp.org/wp-content/uploads/2020/03/Ryan-Kevin-combined-2.png)
The antibiotics marketplace collapse: It’s just math, and it’s a solvable equation – by Ryan Cirz and Kevin Krause
more![Inhaled antimicrobials: Do we get the drug to the bug?](https://revive.gardp.org/wp-content/uploads/2020/02/GARDP_REVIVE_Poster_April2020_HT1_new-colours-scaled-1.jpg)